CRISPR/Cas13X-assisted programmable and multiplexed translation regulation for controlled biosynthesis
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkae1293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Xianhao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, No. 1800, Lihu Avenue, Binhu District, Wuxi 2…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacillus subtilis, CRISPR-Associated Proteins, Bacterial Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Developing efficient gene regulation tools is essential for optimizing microbial cell factories, but most existing tools only modulate gene expression at the transcriptional level. Regulation at the translational level provides a faster dynamic response, whereas developing a programmable, efficient and multiplexed translational regulation tool remains a challenge. Here, we have developed CRISPRi and CRISPRa systems based on hfCas13X that can regulate gene translation in Bacillus subtilis. First, we constructed a CRISPRi system to regulate gene translation based on catalytically deactivated hfCas13X (dhfCas13X). Second, we designed unique mRNA–crRNA pairs to construct DiCRISPRa (degradation-inhibited CRISPRa) and TsCRISPRa (translation-started CRISPRa) systems, which can activate downstream gene translation by enhancing mRNA stability or initiating mRNA translation. In addition, we found that fusing dhfCas13X with the RNA-binding chaperone BHfq significantly improved the activation efficiency of the DiCRISPRa and TsCRISPRa systems (43.2-fold). Finally, we demonstrated that the constructed CRISPR systems could be used to optimize the metabolic networks of two biotechnologically relevant compounds, riboflavin and 2′-fucosyllactose, increasing their titers by 3- and 1.2-fold, respectively. The CRISPRa and CRISPRi systems developed here provide new tools for the regulation of gene expression at the translation level and offer new ideas for the construction of CRISPRa systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, Jiangnan University, No. 1800, Lihu Avenue, Binhu District, Wuxi 214122, China.
- Science Center for Future Foods, Ministry of Education, Jiangnan University, No. 1800, Lihu Avenue, Binhu District, Wuxi 214122, China.
- Department of Bioengineering and Centre for Synthetic Biology, Imperial College London, South Kensington Campus, Exhibition Road, London SW7 2AZ, UK.
ORCID-Profile: Yanfeng Liu, Rodrigo Ledesma-Amaro, Long Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
- Jiangsu Basic Research Center for Synthetic Biology
Zitieren
APA
Xu, X., Lv, X., Liu, Y., Li, J., Du, G., Chen, J., Ledesma-Amaro, R., & Liu, L. (2025). CRISPR/Cas13X-assisted programmable and multiplexed translation regulation for controlled biosynthesis. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1293
Vancouver
Xu X, Lv X, Liu Y, Li J, Du G, Chen J, et al. CRISPR/Cas13X-assisted programmable and multiplexed translation regulation for controlled biosynthesis. Nucleic Acids Research. 2025. doi:10.1093/nar/gkae1293
BibTeX
@article{Xu2025,
author = {Xu, Xianhao and Lv, Xueqin and Liu, Yanfeng and Li, Jianghua and Du, Guocheng and Chen, Jian and Ledesma-Amaro, Rodrigo and Liu, Long},
title = {CRISPR/Cas13X-assisted programmable and multiplexed translation regulation for controlled biosynthesis},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkae1293}
}
EUVIMED